Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular heterogeneity in histomorphologic subtypes of lung adeno carcinoma represents a challenge for treatment decision.

Neoplasia (New York, N.Y.) - 1 Mar 2024

Kolb Tobias, Müller Sarah, Möller Peter, Barth Thomas F E, Marienfeld Ralf

Abstract excerpt

Lung cancer is the leading cause in cancer related death, with non-small cell lung cancer (NSCLC) being the most frequent subtype. The importance of NSCLC is reflected by the various targeted therapy options especially for NSCLC adenocarcinomas (lung adeno carcinoma (LUAD)) as well as a set of options for immune therapies. However, despite these therapy advances, the majority of patients do not show a long-term...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Adenocarcinoma of Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers, Tumor

Share to Carcinoma, Non-Small-Cell Lung

Share to Lung Cancer Treatments and Mutations

Share to Lung Neoplasms

Share to Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 38310709
DOI: 10.1016/j.neo.2023.100955
PMCID: PMC10848034

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular heterogeneity in histomorphologic subtypes of lung adeno carcinoma represents a challenge for treatment decision.PMID 38310709Read ↗

Mutational landscape and clonal diversity of pulmonary adenoid cystic carcinoma.Semantic proximity Read ↗

Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma.Semantic proximity Read ↗

Single-cell and spatial transcriptome characterize coinhibitory cell-cell communications during histological progression of lung adenocarcinomaSemantic proximity Read ↗

Integrated genomic and immunophenotypic profiling reveals monoclonal origin, smoking-driven evolution and heterogeneous microenvironment in pulmonary adenosquamous carcinoma.Semantic proximity Read ↗

Mechanisms of Progression and Heterogeneity in Multiple Nodules of Lung AdenocarcinomaSemantic proximity Read ↗

Clonal dynamics and Stereo-seq resolve origin and phenotypic plasticity of adenosquamous carcinomaSemantic proximity Read ↗

Molecular profiling of lung adenosquamous carcinoma: hybrid or genuine type?Semantic proximity Read ↗

Establishment, characterization, and drug screening of low-passage patient individual non-small cell lung cancer in vitro models including the rare pleomorphic subentitySemantic proximity Read ↗

Molecular differences across invasive lung adenocarcinoma morphological subgroupsSemantic proximity Read ↗

Molecular and Genetic Advances in Small Cell Lung Cancer Landscape: From Homogeneity to Diversity.Semantic proximity Read ↗

Integrative Multi-omics Guides PD-1 Blockade Therapy in the Rare and Aggressive Colorectal Adenosquamous CarcinomaSemantic proximity Read ↗

Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.